CompletedNCT05305001

Germline Mutations Associated With Hereditary Pancreatic Cancer in Unselected Patients With Pancreatic Cancer in Mexico

Studying Familial pancreatic carcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Principal Investigator
Fidel D Huitzil Meléndez, MD
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Intervention
Invitae Multi-Cancer Panel ®(genetic)
Enrollment
107 target
Eligibility
18 years · All sexes
Timeline
2020 – 2022

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05305001 on ClinicalTrials.gov

Other trials for Familial pancreatic carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Familial pancreatic carcinoma →

← Back to all trials